Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1582137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Isadora Alonso Corrêa und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Genética e Imunologia das Infecções Virais, Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal …. Hauptthemen laut MEDLINE: SARS-CoV-2, Virus Replication, RNA, Viral, Coronavirus Nucleocapsid Proteins. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.
Abstract (Originalsprache)
Introduction
The COVID-19 pandemic was characterized by the sequential introduction and circulation of distinct SARS-CoV-2 variants, which presented differences in transmission capacity and pathogenicity. However, the relationship between these differences and the replicative capacity of these variants remains to be determined. Our research aimed to compare the biological traits of the SARS-CoV-2 lineages B.1.1.33, and variants Zeta (P.2), Gamma (P.1/P.1.*), Delta (B.1.617.2/AY.*), and Omicron (BA.1).
Methods
We employed three different cellular models susceptible to viral infection to demonstrated the differences in virus binding, entry and total RNA production through RT-qPCR assay and viral infectious progeny by plaque assay. The RNA replication was evaluated by dsRNA immunofluorescence and the viral protein production by western blotting analysis. NGS and RT-qPCR analysis were also used in competition experiments to verify the viral variants dynamic in cell culture.
Results
We found that the differences in viral replication varied according to the cell type, with Omicron BA.1 exhibiting the lowest replication capacity in human pulmonary cells. Additionally, we demonstrated the occurrence of nucleocapsid proteoforms generated during infection and differences in size and number of sites of viral RNA replication for each virus.
Conclusion
These data suggest that factors beyond the initial stages of virus entry influence the efficiency of viral replication among different SARS-CoV-2 variants. Thus, our study underscores the significance of RNA replication and the role of nucleocapsid proteins in shaping the replicative characteristics of SARS-CoV-2 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Genética e Imunologia das Infecções Virais, Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Laboratório de Virologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Laboratório de Metabolismo Macromolecular Firmino Torres de Castro, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Núcleo de Enfrentamento e Estudos de Doenças Infecciosas Emergentes e Reemergentes (NEEDIER), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergência Viral, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
- Departamento de Doenças Infecciosas, Faculdade de Medicina, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Förderung
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
- Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
Zitieren
APA
Corrêa, I. A., de Souza, M. R. M., da Silva, G. P. D., Pimentel, A. B. S. V. M., Calil, P. T., Cunha, M. S., Mariani, D., Brindeiro, R. M., Costa, S. M., Simas, M. C. D. C., Ota, V. A., Pereira, E. C., Siqueira, M. M., Resende, P. C., Galliez, R. M., Faffe, D. S., Silva, R., Castiñeiras, T. M. P. P., Tanuri, A., & da Costa, L. J. (2025). Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1582137
Vancouver
Corrêa IA, de Souza MRM, da Silva GPD, Pimentel ABSVM, Calil PT, Cunha MS, et al. Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1582137
BibTeX
@article{Corra2025,
author = {Corrêa, Isadora Alonso and de Souza, Marcos Romário Matos and da Silva, Gustavo Peixoto Duarte and Pimentel, Anna Beatriz Sampaio Vianna Macedo and Calil, Pedro Telles and Cunha, Marcela Sabino and Mariani, Diana and Brindeiro, Rodrigo de Moraes and Costa, Sara Mesquita and Simas, Maria Clara da Costa and Ota, Victor Akira and Pereira, Elisa Cavalcante and Siqueira, Marilda Mendonça and Resende, Paola Cristina and Galliez, Rafael Mello and Faffe, Debora Souza and Silva, Rosane and Castiñeiras, Terezinha Marta Pereira Pinto and Tanuri, Amilcar and da Costa, Luciana Jesus},
title = {Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1582137}
}
EUVIMED